List of works by Angus Dalgleish

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo.

scientific article

A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy

scientific article

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.

scientific article published on 5 January 2016

Biomarkers for development of cancer vaccines

scientific article published on 01 February 2006

Biomarkers for the development of cancer vaccines: current status

scientific article published on January 2006

Cancer immunotherapy: an embarrassment of riches?

scientific article

Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors.

scientific article published in December 2017

Cell based cancer vaccines: regulatory and commercial development

scientific article published on September 2007

Correlation of Antibody Responses to a Peptide Antigen gp120-C5501-512/gp41732-744 with HIV Disease Progression

scientific article published on 4 January 2017

Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transduction.

scientific article published in January 2003

Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination

scientific article published on 28 January 2005

Current status and future applications of cellular therapies for cancer

scientific article published on April 2011

Developments in HIV-1 immunotherapy and therapeutic vaccination.

scientific article

Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.

scientific article published in December 2004

Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer.

scientific article published on June 2012

HIV-1 step study

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer

scientific article published on 6 November 2014

Identification of circulatory biomarkers from clinical trial samples

scientific article published on 4 November 2015

Immunotherapeutic potential of whole tumour cells.

scientific article

Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy

scientific article

Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy

scientific article

Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine

scientific article published on 7 May 2011

Infection, immunoregulation, and cancer.

scientific article

Interview with Professor Angus Dalgleish

scientific article

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

scientific article

Lenalidomide: a novel anticancer drug with multiple modalities

scientific article published on 01 January 2009

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

scientific article

Melanoma vaccines

scientific article published on 01 November 2004

Mycobacterial immunotherapy for prostate cancer: where can we go from here?

scientific article published on 01 April 2020

Not so SMART?

scientific article published on 01 May 2009

Novel immunotherapeutic approaches to prostate cancer

scientific article

Novel strains of Salmonella typhimurium as potential vectors for gene delivery

scientific article published in September 2004

Overcoming technical challenges in the development of cancer vaccines

scientific article published on July 2007

Overview of tumor cell-based vaccines

scientific article published on September 2006

Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

scientific article published on 21 June 2011

Prevention

scientific article published on 01 June 2004

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol

article

Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.

scientific article published on May 2013

Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature

scientific article published on 18 January 2014

Surgical management of intraabdominal metastases from melanoma: role of the neutrophil to lymphocyte ratio as a potential prognostic factor

scientific article published on 01 June 2014

Technical challenges facing therapeutic cancer vaccines

scientific article published on March 2008

The importance for immunoregulation for long-term cancer control

scientific article

The potential of immunomodulatory drugs in the treatment of solid tumors

scientific article published on September 2010

Therapeutic cancer vaccines

scientific article published on 02 August 2007

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.

scientific article

Tumor antigens as surrogate markers and targets for therapy and vaccines

scientific article published on January 2007

Whole-cell vaccines: A failure or a success waiting to happen?

scientific article published on February 2010